Analysis Group

June 5, 2026 Analysis Group congratulates Dr. Amol S Navathe on his appointment as chair of the Medicare Payment Advisory Commission (MedPAC). His three-year appointment was announced in May 2026. Dr. Navathe is a health economist and a staff physician at Penn Presbyterian Medical Center. He specializes in the design and evaluation of health care payment and reimbursement models, health plan coverage, and medical service and prescription drug pricing, among other topics.

June 3, 2026 A central policy challenge in early-stage cancer care is how to evaluate and provide timely access to therapies while evidence is still evolving. Early detection and treatment can improve the likelihood of successful treatment and survival, underscoring the need for timely evidence on therapies in early-stage settings.

June 3, 2026 Analysis Group was retained on behalf of Armistice Capital, Armistice Capital Master Fund, and two Armistice executives, the defendants in a Rule 10b-5 securities fraud class action involving Vaxart, a clinical-stage biotech company developing oral recombinant vaccines.

June 2, 2026 Price discrimination claims under the Robinson-Patman Act (RPA) have seen a resurgence in recent years, particularly in cases alleging that suppliers charged different prices for the same goods to competing downstream resellers, known as secondary-line claims. In parallel, firms are increasingly varying the promotion and pricing of their products across brick-and-mortar, e-commerce, and wholesale channels to accommodate the preferences and purchasing behavior of end customers.

June 1, 2026 Fifteen Analysis Group consultants have been recognized as among the top economic experts for intellectual property (IP) matters in the IAM Patent 1000 – 2026. For this annual guide identifying outstanding patent professionals around the globe, Intellectual Asset Management (IAM) conducts extensive research, including interviews with attorneys and industry participants.

2026 ASCO Annual Meeting May 29–June 2, 2026 Chicago, IL/Online Members of Analysis Group’s HEOR, Epidemiology & Market Access practice will present seven posters at the 2026 ASCO Annual Meeting. The program will feature a range of educational and scientific sessions on cancer research, treatment, and patient care. Posters will be presented in Hall A of McCormick Place.

Is it Junk or is it Transparency? June 3, 2026 American Bar Association Antitrust Law Section 9:00–10:00 a.m. (PT) / 12:00–1:00 p.m. (ET) Managing Principal Rebecca Kirk Fair will moderate the American Bar Association Antitrust Law Section webinar Is it Junk or is it Transparency?. Presented by the Pricing Conduct Committee, the program will examine evolving US and Canadian policies on deceptive marketing, price transparency, class action trends, and related economic and competitive effects.

17th Summit on Biosimilars & Innovator Biologics June 2, 2026 American Conference Institute (ACI) New York, NY 12:00–1:00 p.m. (PT) / 3:00–4:00 p.m. (ET) Vice President Andrea Hugill will join the panel Manufacturing Patents as the New Battleground: Protecting Biologics Manufacturing at the American Conference Institute’s 17th Summit on Biosimilars & Innovator Biologics.

May 28, 2026 Analysis Group is pleased to announce the promotion of Rene Befurt and Joshua White to managing principal and Carletta Wong to principal.

May 26, 2026 As the use of GLP-1 medications continues to rise in the US, their effect on rates of metabolic bariatric surgery (MBS) as a treatment for obesity and related cardiometabolic conditions remains an important question for patients, providers, and policymakers.